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Inflammasome-mediated caspase-1 activation is
involved in cell death and the secretion of the proin-
flammatory cytokine interleukin-1b (IL-1b). Although
the dynamics of caspase-1 activation, IL-1b secre-
tion, and cell death have been examined with bulk
assays in population-level studies, they remain
poorly understood at the single-cell level. In this
study, we conducted single-cell imaging using a ge-
netic fluorescence resonance energy transfer sensor
that detects caspase-1 activation. We determined
that caspase-1 exhibits all-or-none (digital) activa-
tion at the single-cell level, with similar activation ki-
netics irrespective of the type of inflammasome or
the intensity of the stimulus. Real-time concurrent
detection of caspase-1 activation and IL-1b release
demonstrated that dead macrophages containing
activated caspase-1 release a local burst of IL-1b
in a digital manner, which identified these macro-
phages as the main source of IL-1b within cell popu-
lations. Our results highlight the value of single-cell
analysis in enhancing understanding of the inflam-
masome system and chronic inflammatory diseases.
INTRODUCTION
Macrophages (MFs) play crucial roles in homeostasis by
clearing dead cells and connecting innate immunity with adap-974 Cell Reports 8, 974–982, August 21, 2014 ª2014 The Authorstive immunity (Mosser and Edwards, 2008). When MFs detect
pathogen-associated molecular patterns (PAMPs) derived from
infection or damage-associated molecular patterns (DAMPs)
originating from injured tissues, they secrete various types of cy-
tokines to induce inflammation or tissue repair. Interleukin-1b
(IL-1b) is a key cytokine that evokes an inflammatory response,
and its secretion is mainly regulated by caspase-1, a member
of the cysteine-protease family of caspases (Denes et al., 2012).
Caspase-1 is synthesized as an inactive zymogen and then
activated via proteolytic cleavage, a process regulated by intra-
cellular multiprotein complexes called inflammasomes (Martinon
et al., 2002; Rathinam et al., 2012); the inflammasomes detect
PAMPs and DAMPs by using distinct intracellular pattern-recog-
nition receptors such as NLRP3 (Nod-like receptor family, pyrin
domain containing 3), NLRC4 (Nod-like receptor family, CARD
domain containing 4), and AIM2 (absent in melanoma 2) (Marti-
non et al., 2002; Rathinam et al., 2012). When PAMPs or DAMPs
are detected, procaspase-1 is recruited directly through interac-
tions between the pattern-recognition receptors and procas-
pase-1 or indirectly through adaptor proteins such as ASC
(apoptosis-associated speck-like protein containing CARD)
(Schroder and Tschopp, 2010). The recruited procaspase-1 is
activated through autoproteolytic cleavage mediated by prox-
imity-induced multimerization. In addition to regulating proin-
flammatory cytokines, caspase-1 activation has been shown to
cause cell death (Miura et al., 1993). In certain cases, caspase-
1 is necessary for the execution of necrotic inflammatory cell
death, called pyroptosis, in MFs in response to intracellular bac-
terial infection (Fink and Cookson, 2005; Miao et al., 2010). How-
ever, in other cases, although caspase-1 is activated in response
to various PAMPs or DAMPs, deleting or inhibiting caspase-1 is
insufficient for preventing cell death (Broz et al., 2010; Pierini
et al., 2012).
Given the aforementioned studies, the activation of most in-
flammasomes is considered to typically converge on caspase-1
activation, which couples the secretion of the proinflammatory
cytokine IL-1b and cell death. However, most of the information
on inflammasomes and caspase-1 has been obtained frompopu-
lation-level studies conducted using bulk assays such as western
blotting and ELISA, mainly because of technical limitations and
because of the unique characteristics of caspase-1 such as rapid
secretion after activation and rapid inactivation (Keller et al., 2008;
Walsh et al., 2011). Emerging evidence suggests that population
data do not faithfully reflect how single cells respond to stimuli
(Tay et al., 2010). Thus, the mechanism through which individual
cells activate caspase-1 by means of distinct inflammasomes
and secrete IL-1b in response to inflammatory stimuli remains un-
clear. Determining signaling dynamics at the single-cell level not
only expands the general understanding of how biological sys-
temsworkbut alsocomplements in vivostudies that examinecells
residing in complex contexts (Tay et al., 2010). Single-cell mea-
surement of caspase-1 activity at high spatiotemporal resolution
is required to fully understand the dynamics of caspase-1 activa-
tion and the direct relationship between caspase-1 activation and
its associated outcomes, IL-1b secretion and cell death.
Tomonitor caspase-1 activity at the single-cell level, we devel-
oped SCAT1, a genetically encoded fluorescent sensor for de-
tecting caspase-1 activation based on fluorescence resonance
energy transfer (FRET). Using peritoneal MFs (PMFs) obtained
from transgenic mice expressing SCAT1, we determined that
caspase-1 is activated in a digital manner at the single-cell level
in response to various types of inflammasomes. Interestingly,
the kinetics of caspase-1 activation was similar regardless of
the strength and type of stimuli. Moreover, by combining the
SCAT1 system and a newly developed technique to measure
protein secretion at single-cell resolution, we identified dying
MFs that contained activated caspase-1 as the source of
secreted IL-1b in PMF populations.
RESULTS
Real-Time Detection of Caspase-1 Activation through
the NLRP3 Inflammasome with SCAT1, a Genetically
Encoded Probe Developed for Monitoring
Caspase-1 Activation
Probes based on FRET technology can provide critical informa-
tion on the dynamics and activities of endogenous enzymes in
living cells (Aoki et al., 2013). We previously generated a genet-
ically encoded probe called SCAT3 (sensor for caspase-3 acti-
vation based on FRET) and monitored apoptotic caspase-3 acti-
vation in vitro and in vivo (Kuranaga et al., 2011; Nakajima et al.,
2011; Takemoto et al., 2003, 2007; Yamaguchi et al., 2011).
SCAT comprises 2 fluorescent proteins—enhanced cyan fluo-
rescent protein (ECFP) and Venus—that are connected by a
linker sequence that contains caspase cleavage sites (Figure 1A).
Upon caspase activation, the linker is cleaved and the FRET be-
tween ECFP and Venus is disrupted, which can be detected in
real time with fluorescence microscopy. To detect real-time acti-
vation of caspase-1, we constructed SCAT1 containing YVAD(a consensus peptide sequence preferentially cleaved by cas-
pase-1) in its linker sequence instead of the DEVD sequence pre-
sent in SCAT3 (Figure 1A).
The results of in vitro cleavage assays demonstrated that
SCAT1 was preferentially cleaved by activated human cas-
pase-1 (Figure S1A). Notably, SCAT1 was barely processed by
activated human caspase-4 and caspase-5, which represent
potential functional orthologs of murine caspase-11. The speci-
ficity of SCAT1 cleavage upon caspase-1 activation was also
confirmed in living cells with the caspase-1-specific inhibitor
z-YVAD-fmk or by genetic deletion of caspase-1/11 (Figure S1B;
see below for a detailed explanation). We generated a gene-tar-
geting mouse line in which the CAG-promoter-loxP-STOP-loxP-
SCAT1 gene cassette was knocked into the Rosa26 locus. In
this knockin mouse line, SCAT1 expression depended on Cre re-
combinase expression (Figure S1C); by mating these mice with
mice that ubiquitously expressed Cre, we generated mice that
expressed SCAT1 in all tissues. We obtained peritoneal MFs
(PMFs) expressing SCAT1 from these mice. The possibility
that overexpressed SCAT1, an exogenous substrate of cas-
pase-1, might prevent the endogenous function of caspase-1
was excluded by our observation that IL-1b secretion and
caspase-1 cleavage occurred similarly in PMFs derived from
SCAT1 (wild-type) and SCAT1+ mice after inflammasome-
activation stimulated with lipopolysaccharide (LPS) + ATP or
poly(dA:dT) (Figures S1D and S1E).
Various pathogenic, endogenous, and environmental stimuli
can activate the NLRP3 inflammasome after priming with
LPS or other Toll-like receptor ligands (Latz et al., 2013). We
examined whether SCAT1 can enable real-time detection of
caspase-1 activation induced by canonical activators of the
NLRP3 inflammasome at the single-cell level. PMFs collected
fromSCAT1 knockinmicewere stimulatedwith an environmental
danger signal (silica crystals) after LPS priming and were
observed continuously under a confocal microscope to monitor
the time course of changes in SCAT1 (Venus and ECFP) inten-
sities. The SCAT1 Venus/ECFP (V/C) ratio decreased rapidly
and dramatically (Figures 1B and 1C; Movie S1) in some of the
cells after stimulation, indicating that caspase-1 was activated;
the time of caspase-1 activation varied among cells (Figures
S2A and S2B). Moreover, adding the caspase-1-specific
inhibitor z-YVAD-fmk abolished the dramatic reduction in the
SCAT1 V/C ratio and the cleavage of SCAT1 (Figures 1B, 1C,
S1B, S2A, and S2B; Movie S1), indicating that SCAT1 accurately
detected caspase-1 activation.We also confirmed that apoptotic
caspases were not activated in PMFs stimulated with LPS + sil-
ica; SCAT3, the indicator of caspase-3 activation, did not detect
apoptotic activation of caspases in these PMFs (Figure S2C).
Time-lapse imaging showed that SCAT1 fluorescence disap-
peared after caspase-1 activation, but the fluorescence was
lost even when caspase-1 activation was prevented by its inhib-
itor (Figure 1B). This loss of fluorescence indicated cell death
accompanying membrane rupture because it coincided with
the cells becoming positive for TO-PRO-3 or propidium iodide
staining (Figure 1D; Movie S1). These data indicated that
SCAT1 can faithfully detect NLRP3 inflammasome-induced acti-
vation of caspase-1 and subsequent cell death in real time at the
single-cell level. Interestingly, the dynamics of SCAT1 V/C ratiosCell Reports 8, 974–982, August 21, 2014 ª2014 The Authors 975
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in PMFs exhibited only two patterns: no decrease or dramatic
decrease.
Real-Time Detection of Caspase-1 Activation via AIM2
and NLRC4 Inflammasomes
Next, we determined whether SCAT1 detects caspase-1 acti-
vation via two other types of inflammasomes, AIM2 and
NLRC4, in addition to activation by the NLRP3 inflammasome.
The AIM2 inflammasome is activated by poly(dA:dT) transfec-
tion with or without LPS priming (Fernandes-Alnemri et al.,
2009; Hornung et al., 2009). The SCAT1 V/C ratio dramatically
decreased in some PMFs after poly(dA:dT) transfection in a
manner independent of LPS priming (Figures 2A, 2B, and
S3A–S3C; Movie S2). This decrease was abolished when the
caspase-1 inhibitor was added to SCAT1+ PMFs or SCAT1+
caspase-1/11-deficient PMFs (Figures 2A, 2B, and S3B–S3D;
Movie S2) (Kayagaki et al., 2011; Kuida et al., 1995). Regard-
less of the presence or absence of caspase-1 activity, cell
death occurred, which was indicated by the disappearance of
SCAT1 fluorescence (shown as a loss of ECFP intensity in
the SCAT1 V/C ratio graphs in Figures 1B, 1D, 2A, 2C, S2C,
S3A, S4A, and S4B).
The NLRC4 inflammasome is activated by pathogenic pro-
teins derived from various bacteria, including Salmonella sero-
type Typhimurium, Legionella pneumophila, and Pseudomonas
aeruginosa (Franchi et al., 2012). SCAT1 V/C ratios rapidly
decreased after infection with S. Typhimurium SL1344 (Fig-
ure 2C), but not after infection with S. TyphimuriumD invGsseD
(a strain that exhibits little capability to induce inflammasomes)
or when caspase-1 was inhibited (Figures S4A and S4B; Movie
S3). Taken together, these data indicate that SCAT1 detects
caspase-1 activation and subsequent cell death that occur via
activation of the AIM2, NLRC4, and NLRP3 inflammasomes.
Nearly Identical Kinetics of Caspase-1 Activation and
the Resulting Inflammatory Cell Death in Response to
Distinct Stimuli
The results of our SCAT1 imaging suggested that caspase-1
activation is a digital, all-or-none response. To quantify and char-
acterize the caspase-1 activation further, we conducted kinetic
analyses of caspase-1 activation at the single-cell level. We first
investigated whether the kinetics of caspase-1 activation varied
in relation to the distinct types of inflammasomes at the single-
cell level. The AIM2, NLRP3, and NRLC4 inflammasomes stimu-
lated similar time courses of change in the SCAT1 V/C ratio in
response to poly(dA:dT), silica, and S. Typhimurium (Figure 3A).Figure 1. Real-Time Detection of Caspase-1 Activation through the N
Monitoring Caspase-1 Activation
(A) Schematic representation of SCAT1, a fluorescence resonance energy tra
sequences of SCAT3 (caspase-3 cleavage site DEVD) and SCAT1 (caspase-1 cl
(B and C) Live-imaging analysis of SCAT1+macrophages (PMFs) primed with lipo
ratio images of PMFs treated with LPS (1 mg/ml) + silica (0.5 mg/ml) and LPS (
intensities of ECFP and Venus or SCAT1 V/C ratio changes of PMFs indicated by a
ratio are presented asmeans and standard deviation (SD) (C). YVAD: z-YVAD-fmk
representative of three or more independent experiments in (B); n > 4 under eac
(D) Live-imaging analysis of TO-PRO-3 staining of SCAT1+ PMFs under the LPS +
and TO-PRO-3 uptake. Right, time-course of SCAT1 V/C-ratio change and TO-P
independent experiments.Next, we examined whether varying the stimulus intensity
affects the dynamics of caspase-1 activation at the single-cell
level. We used poly(dA:dT) as a model stimulus because it
does not require LPS priming, which may induce unexpected
disparities in cellular competence to stimulus. We transfected
poly(dA:dT) into PMFs at five concentrations and measured
the kinetics of caspase-1 activation. The results revealed that
the kinetics of caspase-1 activation (change in the relative
SCAT1 V/C ratio over time) was similar across all stimulus inten-
sities (Figure 3B). However, stimulus intensity affected the num-
ber of PMFs that contained activated caspase-1 and subse-
quently underwent cell death, and this number increased in a
dose-dependent manner (Figure 3C). Moreover, IL-1b produc-
tion measured using ELISA, a bulk assay, exhibited a similar
trend in the number of PMFs that contained activated cas-
pase-1 and underwent cell death under LPS-primed conditions
(Figure 3D), as previously reported (Nystro¨m et al., 2013).
These results further indicated that caspase-1 is activated in a
digital manner. Varying the stimulus intensity or the inflamma-
some type did not affect the kinetics of caspase-1 activation at
the single-cell level; however, at the population level, it influ-
enced the frequency of cell death as a result of inflammasome
activation.
Dying PMFs Containing Activated Caspase-1 as the
Main Source of Secreted IL-1b
Our results raised the possibility that PMFs undergoing cell
death immediately after caspase-1 activation are the main
source of secreted IL-1b. Although this possibility has long
been considered, single-cell studies are required to test the pos-
sibility directly and precisely, and few such investigations have
been conducted because of technical limitations (Perregaux
and Gabel, 1994). Our SCAT1 system allowed us to perform
concurrent live imaging of caspase-1 activation, cell death,
and IL-1b secretion and combine it with quantitative monitoring
of IL-1b secretion in real time at single-cell resolution using a
method that we recently developed (Shirasaki et al., 2014).
SCAT1+ PMFs seeded on a microwell device were used to mea-
sure caspase-1 activation and IL-1b secretion at single-cell res-
olution on total internal reflection fluorescent microscopy. After
stimulation with poly(dA:dT), the cellular activity of caspase-1
and subsequent IL-1b release from single cells were successfully
detected (Figure 4A; Movie S4). IL-1b was secreted in massive
amounts immediately after caspase-1 activation, and we there-
fore called this release an IL-1b burst. Notably, the IL-1b burst
coincided with the time of cell death, which was indicated byLRP3 Inflammasome with SCAT1, a Genetically Encoded Probe for
nsfer biosensor developed for monitoring caspases activation. Right, linker
eavage site YVAD).
polysaccharide (LPS) and stimulated with silica. Top, SCAT1 Venus/ECFP (V/C)
1 mg/ml) + silica (0.5 mg/ml) + YVAD (50 mM). Bottom, time course of relative
rrowheads. The percentages of cells in a field that showed reduced SCAT1 V/C
, caspase-1 inhibitor. Scale bar, 50 mm; arrowhead: representative cell. Data are
h condition, and ***p < 0.001 (one-way analysis of variance [ANOVA]) in (C).
silica stimulation condition. Left, time-lapse images of SCAT1 V/C ratio, ECFP,
RO-3 uptake in the PMF. Scale bar, 50 mm. Data are representative of three
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Figure 2. Real-Time Detection of Caspase-1 Activation through the AIM2 and NLRC4 Inflammasomes
(A and B) Live-imaging analysis of SCAT1+ PMFs under AIM2 inflammasome activation. Top, SCAT1 V/C ratio changes of SCAT1+ PMFs transfected with LPS
(1 mg/ml) + poly(dA:dT) (1 mg/ml) and LPS (1 mg/ml) + poly(dA:dT) (1 mg/ml) + YVAD (50 mM). Bottom, time course of changes in the relative intensity of ECFP and
Venus or SCAT1 V/C ratios of PMFs indicated by arrowheads. The percentages of cells in a field that showed a reduction in the SCAT1 V/C ratio are presented as
means and SD (B). Scale bar, 50 mm; arrowhead: representative cell. Data are representative of three independent experiments in (A); n > 3 under each condition,
***p < 0.001 (one-way ANOVA) in (B).
(C) Live-imaging analysis of SCAT1+ PMFs under NLRC4 activation. Left, SCAT1 V/C ratio images of PMFs primed with LPS (1 mg/ml) and infected with
Salmonella Typhimurium (MOI 20). Right, time course of changes in the relative intensities of ECFP and Venus or SCAT1 V/C ratios of the PMFs indicated by
arrowheads. Scale bar, 50 mm; arrowhead: representative cell. Data are representative of three independent experiments.the disappearance of SCAT1 fluorescence (52 min in Figures 4A
and 4B). To investigate whether all the cells that exhibited the IL-
1b burst died, we examined the relationship between the IL-1b
signal and cell death. Our results indicated that the cells that978 Cell Reports 8, 974–982, August 21, 2014 ª2014 The Authorssecreted IL-1b also died and that no surviving cells secreted
IL-1b under this condition (Figure 4C). Furthermore, inhibiting
caspase-1 activation did not inhibit cell death but prevented
IL-1b release (Figure 4C). These results clearly demonstrated
Figure 3. Almost Identical Kinetics of Cas-
pase-1 Activation and Resulting Inflamma-
tory Cell Death Induced by Distinct Stimuli
(A and B) Relative SCAT1 V/C ratio changes
before and after caspase-1 activation. PMFs were
stimulated with distinct inflammasome activators
(NLRP3: LPS [1 mg/ml] + silica [0.5 mg/ml], NLRC4:
LPS [1 mg/ml] + S. Typhimurium [MOI 20], and
AIM2: poly[dA:dT] [1 mg/ml]) (A) or transfected with
poly(dA:dT) (0.1, 1, 10, 100, and1,000 ng/ml) (B) and
thenexamined live for 4 hr.Numbers of cells (n) used
for quantifying SCAT1 V/C ratios under various
conditions were (A) 32 for LPS + silica, 26 for LPS +
S. Typhimurium, and 115 for poly(dA:dT). For
poly(dA:dT) in (B), n = 42 (0.1 ng/ml), 78 (1 ng/ml), 64
(10 ng/ml), 88 (100 ng/ml), and 119 (1,000 ng/ml).
x axis, time (min). Data were collected from two or
more independent experiments and are presented
as mean and SD.
(C) Percentages of PMFs that contained activated
caspase-1 and died, as determined based on
the loss of fluorescence in all cells examined under
the microscope. PMFs were transfected with
poly(dA:dT) (0.1, 1, 10, 100, and 1,000 ng/ml) and
imaged live for 3 hr. Data were collected from four
independent experiments and are presented as
mean and SD.
(D) ELISA performed on interleukin (IL)-1b that was secreted into cell culture supernatants from SCAT1+ PMFs. The PMFs were primed with LPS (1 mg/ml) for 4 hr
and transfected with poly(dA:dT) (0.1, 1, 10, 100, 1000 ng/ml) for 3 hr. Data were collected from four independent experiments and are presented as mean and SD.that inflammasome-mediated digital activation of caspase-1
couples the IL-1b burst with cell death and that dying cells con-
taining activated caspase-1 are the main source of secreted
IL-1b in PMF populations.
DISCUSSION
This study, which used a probe designed to detect caspase-1
activation, showed that caspase-1 activation is an all-or-none
response at the single-cell level in PMFs. It also demonstrated
that the kinetics of caspase-1 is essentially the same irrespective
of the intensity or types of stimulus. The output of caspase-1
activation is a burst of IL-1b release, which also occurs in an
all-or-none manner as a consequence of digital activation of
caspase-1. However, the mechanisms underlying these digital,
all-or-none responses remain unclear. The assembly of large
oligomeric signalosomes containing members of the Toll-like re-
ceptor interleukin-1 receptor superfamily has been suggested to
be a structural basis for a digital all-or-none response (Ferrao
et al., 2012; Wu, 2013). As well, such higher-order signalosomes
have recently been reported to exist in inflammasomes (Lu et al.,
2014), whichmay be themechanism that dictates the digital acti-
vation of caspase-1.
Caspase-1 activation has long been considered to induce IL-
1b secretion and cell death, and IL-1b secretion is correlated
with cell death (Brough and Rothwell, 2007; Hogquist et al.,
1991; Nystro¨m et al., 2013). However, whether individual cells
that contain activated caspase-1 secrete IL-1b and die has
remained unclear because the investigative methods available
to date have been bulk assays, which cannot address these
questions. Recently, two biosensors that monitor caspase-1and inflammasome activation were reported: a bioluminescence
resonance energy transfer sensor to detect pro-IL-1bprocessing
and a sensor fusion protein of luciferase and pro-IL-1b (Bartok
et al., 2013; Compan et al., 2012). Such luminescence-based
probes are superior to fluorescent probes in that they allow ex-
amination of bulk activity in cell populations or at the tissue level;
however, the cellular resolution and sensitivity of these probes
are insufficient for single-cell analysis within tissues. Further-
more, these sensors appear inadequate from a time-resolution
standpoint for determining the kinetics of rapid caspase-1 acti-
vation within a single cell. By comparison, the indicator we devel-
oped, SCAT1, enables visualization of caspase-1 activation and
measurement of its kinetics at high temporal resolution on the
single-cell level. Although we do not exclude the possibility
that our SCAT1 and IL-1b imaging are insensitive to weak or local
activations of caspase-1 and very low amounts of IL-1b secre-
tion, previous bulk assays including western blotting and ELISA
are less sensitive than our single-cell imaging system and almost
impossible to use to test this possibility. Addressing these issues
requires further technical developments.
Elevated local or systemic IL-1b release caused by compro-
mised inflammasome activation is associated with various
chronic inflammatory diseases such as cryopyrin-associated pe-
riodic syndrome, metabolic disorders, and carcinogenesis in hu-
man and mouse models (Wen et al., 2012; Zitvogel et al., 2012).
Recently, mutations in an NLRP3 protein associated with cryo-
pyrin-associated periodic syndrome were shown to induce
necrotic cell death, which in turn leads to neutrophilic inflamma-
tion (Satoh et al., 2013). Our study clearly demonstrates that
dying MFs containing activated caspase-1 exhibit IL-1b bursts.
Thus, cells located near suchMFs would receive amaximal levelCell Reports 8, 974–982, August 21, 2014 ª2014 The Authors 979
Figure 4. Dying PMFs Containing Activated Caspase-1 as the Main Source of Secreted IL-1b
(A and B) Simultaneous live imaging of SCAT1 V/C-ratio changes and IL-1b secretion in SCAT1+ PMFs primed using LPS (1 mg/ml) and stimulated with
poly(dA:dT) (1 mg/ml). (A) The montage shows time-dependent changes in the intensities of ECFP (the middle row), SCAT1 V/C ratios (the top row), and IL-1b
secretion (the bottom row). (B) The time course of changes in the intensities of ECFP and Venus, SCAT1 V/C ratios, and IL-1b secretion in a representative cell, as
in (A). Scale bar, 50 mm.
(C) Dot-plot representation of the signal intensity of IL-1b secreted from single cells, classified according to cell viability in the absence and presence of treatment
with the caspase-1 inhibitor YVAD. LPS-primed SCAT1+ PMFs were introduced into a microwell array with a fluorescent detection antibody and stimulated with
poly(dA:dT). After incubation for 4 hr, all microwells were scanned to detect the signals of IL-1b secretion and the SCAT1 probe. Cell viability was determined
based on the intensity of SCAT1.of IL-1b locally, even when a low level of circulating IL-1b is
detected systemically. This scenario is highly likely to occur un-
der chronic disease conditions. If the local cells receiving the
burst-released IL-1b exhibit oncogenic potential, strong stimula-
tion by high levels of IL-1b could trigger cellular transformation
under conditions of chronic inflammation. Studies of inflamma-
tory cell death and local bursts of cytokine release in vivo could
offer intriguing and crucial perspectives that will help reveal
the mechanisms underlying chronic inflammatory diseases.
Applying SCAT1 imaging analysis to various chronic inflamma-980 Cell Reports 8, 974–982, August 21, 2014 ª2014 The Authorstory disease models in vivo is challenging but would enhance
our understanding of the involvement of local and continuous in-
flammatory cell death in the pathology of these diseases.EXPERIMENTAL PROCEDURES
Live Imaging of Peritoneal MF Cultures
Live imaging was conducted using an inverted confocal microscope (TCS
SP5; Leica) equipped with a galvo stage and a resonant scanner designed
for fast scanning using an HC PL APO 203/0.70 CS dry objective (Leica).
During imaging, dishes of cells were placed in a humidified cell-culture incu-
bator and continuously supplied with 5%CO2/air at 37
C (Tokai Hit Company).
ECFP was excited using a 442 nm diode laser (10%–25% power), and the
emissions of ECFP and Venus (FRET) were detected simultaneously using
two detectors (Leica HyD) and a resonant scanner (8,000 Hz; Leica). Propidium
iodide and TO-PRO-3 were excited using 561 and 633 nm diode lasers (15%
power), respectively. Images (512 3 512 pixels) were acquired at intervals of
1–2 min, and the z slices obtained were 4 mm thick (total of 9–12 slices/time
point), depending on the experiment. To inhibit caspase-1 pharmacologically,
we used z-YVAD-fmk (50 mM final concentration; 1/1,000 dilution of a 50 mM
stock prepared in dimethylsulfoxide).
PMFs were plated on four-well glass-bottom dishes (Greiner Bio-One) and
primed using LPS (1 mg/ml) or PBS for 4–12 hr before stimulation. All live-im-
aging analyses were initiated after stimulating inflammasomes by using this
procedure, and live images were acquired for 3–4 hr under all conditions
tested.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and four movies and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.07.012.
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